Oxygen therapy in advanced COPD: in whom does it work?
- PMID: 20496302
- DOI: 10.1055/s-0030-1254073
Oxygen therapy in advanced COPD: in whom does it work?
Abstract
Supplemental oxygen therapy is commonly used in patients with advanced chronic obstructive pulmonary disease (COPD) and severe hypoxemia at rest. Use of oxygen in these patients is justified by studies showing a mortality benefit. However, the use of oxygen in other patients with advanced COPD has not clearly been established. Long-term studies assessing not only mortality but also other outcomes that are important to patients and physicians such as dyspnea, health status, and exercise capacity are lacking. This article reviews the available studies of the use of supplemental oxygen in patients with less severe hypoxemia at rest during the day, hypoxemia occurring only at night, and hypoxemia occurring only with exercise. With the knowledge that studies in patients with advanced COPD and less severe hypoxemia are limited, recommendations are provided on oxygen use in these groups of patients.
Similar articles
-
Long-Term Oxygen Therapy in COPD Patients Who Do Not Meet the Actual Recommendations.COPD. 2017 Jun;14(3):351-366. doi: 10.1080/15412555.2017.1319918. Epub 2017 May 16. COPD. 2017. PMID: 28506089 Review.
-
Long-term oxygen therapy in COPD: evidences and open questions of current indications.Monaldi Arch Chest Dis. 2010 Mar;73(1):34-43. doi: 10.4081/monaldi.2010.311. Monaldi Arch Chest Dis. 2010. PMID: 20499792 Review.
-
[Oxygen therapy in exercise-induced hypoxemia improves physical capacity and reduces dyspnea in patients with COPD].Ugeskr Laeger. 2011 Jun 6;173(23):1635-40. Ugeskr Laeger. 2011. PMID: 21645481 Review. Danish.
-
Supplemental oxygen in patients with stable chronic obstructive pulmonary disease: evidence from Nocturnal Oxygen Treatment Trial to Long-term Oxygen Treatment Trial.Curr Opin Pulm Med. 2018 Mar;24(2):179-186. doi: 10.1097/MCP.0000000000000461. Curr Opin Pulm Med. 2018. PMID: 29319542 Review.
-
Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year.J Bras Pneumol. 2018 Sep-Oct;44(5):390-397. doi: 10.1590/S1806-37562017000000019. J Bras Pneumol. 2018. PMID: 30517340 Free PMC article.
Cited by
-
Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Lung India. 2013 Jul;30(3):228-67. doi: 10.4103/0970-2113.116248. Lung India. 2013. PMID: 24049265 Free PMC article.
-
Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis.Ont Health Technol Assess Ser. 2012;12(7):1-64. Epub 2012 Mar 1. Ont Health Technol Assess Ser. 2012. PMID: 23074435 Free PMC article. Review.
-
Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.J Microbiol. 2014 Mar;52(3):211-26. doi: 10.1007/s12275-014-4068-2. Epub 2014 Mar 1. J Microbiol. 2014. PMID: 24585052 Review.
-
The Long-Term Oxygen Treatment Trial for Chronic Obstructive Pulmonary Disease: Rationale, Design, and Lessons Learned.Ann Am Thorac Soc. 2018 Jan;15(1):89-101. doi: 10.1513/AnnalsATS.201705-374SD. Ann Am Thorac Soc. 2018. PMID: 29087741 Free PMC article.
-
Effect of pulmonary TNF-α overexpression on mouse isolated skeletal muscle function.Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R1025-31. doi: 10.1152/ajpregu.00126.2011. Epub 2011 Jun 22. Am J Physiol Regul Integr Comp Physiol. 2011. PMID: 21697519 Free PMC article.
Publication types
MeSH terms
Grants and funding
- HHSN268200736183C/PHS HHS/United States
- HHSN268200736184C/PHS HHS/United States
- HHSN268200736186C/PHS HHS/United States
- HHSN268200736187C/PHS HHS/United States
- HHSN268200736188C/PHS HHS/United States
- HHSN268200736189C/PHS HHS/United States
- HHSN268200736190C/PHS HHS/United States
- HHSN268200736191C/PHS HHS/United States
- HHSN268200736192C/PHS HHS/United States
- HHSN268200736193C/PHS HHS/United States
- HHSN268200736194C/PHS HHS/United States
- HHSN268200736195C/PHS HHS/United States
- HHSN268200736196C/PHS HHS/United States
- HHSN268200736197C/PHS HHS/United States
- HSN268200736185C/PHS HHS/United States
- Y1-HR-7019-01/HR/NHLBI NIH HHS/United States
- Y1-HR-8076-01/HR/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical